Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 72, Issue 2, 2002, Pages 179-183

  Rammohan, K W ^a   Rosenberg, J H ^b   Lynn, D J ^a   Blumenfeld, A M ^b   Pollak, C P ^a   Nagaraja, H N ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SOMNOLENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM AGENTS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PILOT PROJECTS; SINGLE-BLIND METHOD; TREATMENT OUTCOME; WAKEFULNESS;

EID: 0036152780     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.72.2.179     Document Type: Article

References (23)

1. Mechanisms and management of fatigue in progressive neurorogical disorders
2. The impact of fatigue on patients with multiple sclerosis
3. Symptomatic fatigue in multiple sclerosis
4. Amantadine therapy for fatigue in multiple sclerosis
5. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subiects
6. Fatigue therapy in multiple sclerosis: Results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo
7. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis
8. Amantadine treatment of fatigue associated with multiple sclerosis
9. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis
10. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy
11. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
12. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
13. Health-related quality of life effects of modafinir for treatment of narcolepsy
14. Effect of Provigil® (modafinil) on the quality of life and mood of patients who previously received unsatisfactory treatment with dextroamphetamine, methylphenidate, or pemoline for excessive daytime sleepiness associated with narcolepsy
15. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
16. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus
17. A new method for measuring daytime sleepiness: The Epworth sleepiness scale
18. Long term efficacy, safety, and dosing profile of Provigil (modafinil) for the treatment of excessive daytime sleepiness associated with narcolepsy
19. Modafinil improves cognitive function in aged rats measured by a delayed alternation task
20. Non-amphetamine awakening agent modafinil induces feeding changes in the rat
21. The clinical diagnosis of the narcoleptic syndrome